Ceeable is a digital blindness test that is administered through a tablet offering patients a much more efficient and cost-effective solution to checking for blindness. The test uses data scoring metrics to scan sight and offer peer-reviewed stats to help create accurate diagnosis.
Traditionally eye tests that check for blindness can cause upwards of $25,000 making them one of the more expensive health tests. The Ceeable brings the costs down to affordable levels with the use of a tablet rather than machines to survey eyesight. The program can test the eyes for signs of retinal degradation, glaucoma and more with equally as effective technology for a fraction of the cost. The revolutionary technology could help screen more individuals for eye sight problems and save more people with early diagnosis and treatment.
Tablet Blindness Tests
The Ceeable Eye Test Can Be Used to Diagnose Loss of Eyesight
Trend Themes
1. Digital Blindness Tests - The rise of digital blindness tests using tablets offers a more efficient and cost-effective solution for diagnosing loss of eyesight.
2. Affordable Eye Testing - The use of tablets in eye testing provides a more affordable alternative to traditional expensive methods, making it more accessible to a wider population.
3. Enhanced Diagnostic Accuracy - Digital tests using data scoring metrics on tablets provide peer-reviewed stats that contribute to more accurate diagnoses of eye sight problems.
Industry Implications
1. Healthcare Technology - The development and implementation of digital blindness tests on tablets is disrupting the healthcare technology industry, offering more efficient and cost-effective solutions for diagnosing eye problems.
2. Ophthalmology - The use of tablets for eye testing presents opportunities for the ophthalmology industry to improve accessibility and affordability of eye examinations, leading to wider adoption and increased patient engagement.
3. Medical Devices - Digital blindness tests utilizing tablets as a diagnostic tool create disruptive innovation opportunities for the medical device industry, enabling the development of more portable and affordable eye testing solutions.